Latest News

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

We wouldn't blame PagSeguro Digital Ltd. ( NYSE:PAGS ) shareholders if they were a little worried about the fact that...

It looks like John B. Sanfilippo & Son, Inc. ( NASDAQ:JBSS ) is about to go ex-dividend in the next three days. The...

We'd be surprised if Unity Bancorp, Inc. ( NASDAQ:UNTY ) shareholders haven't noticed that the Independent Director...

In April 2026, TransAlta Corporation announced a major leadership transition, with outgoing CFO Joel Hunter becoming President and CEO and Mike Politeski stepping in as EVP and CFO, alongside the appointment of Grant Arnold as EVP, Growth and Chief Commercial Officer. By bringing in executives with deep experience in capital allocation, commercial growth and power markets, TransAlta is reshaping its senior team to support its growth and operational focus. We’ll now examine how appointing an...

The Morning Bull - US Market Morning Update Thursday, Apr, 23 2026 E mini S&P 500 futures are pointing lower this morning, with contracts down about 0.5%, as investors weigh rising borrowing costs against stubborn inflation worries. The US 10 year Treasury yield is sitting near 4.31%, which means mortgages, car loans and corporate borrowing remain relatively expensive. At the same time, persistent US Iran tensions and firm energy prices are keeping the risk of higher fuel and transport costs...

Dividend announcement draws attention to Riley Exploration Permian Riley Exploration Permian (REPX) is attracting fresh interest after its Board of Directors approved a cash dividend of $0.40 per share, payable on May 13, 2026, to shareholders of record on April 29. See our latest analysis for Riley Exploration Permian. The latest dividend announcement comes after a strong run in the share price, with a 90 day share price return of 31.2% and a 1 year total shareholder return of 47.76%,...

Kinder Morgan, NYSE:KMI, and Phillips 66 are advancing their Western Gateway Pipeline joint venture after securing long term shipper commitments. The project is designed to move refined products into key Western U.S. markets, following a successful open season. This marks a project milestone that could influence refined product flows across the region. Kinder Morgan enters this project with shares at $31.81 and a history of very large multi year returns, including about 7x over 5 years. For...

Beiersdorf (XTRA:BEI) is in focus after its Q1 update showed a 4.6% decline in organic net sales, in contrast with 8.2% organic growth in Derma and weaker trends in Nivea and La Prairie. See our latest analysis for Beiersdorf. The Q1 update arrived after a difficult few months, with a 90 day share price return of 25.09% and a 1 year total shareholder return of 38.46%, which points to fading momentum despite the recently reiterated guidance. If this Q1 update has you reassessing your...

Why the new EV order and upcoming earnings matter for Amprius Technologies Amprius Technologies (AMPX) has drawn fresh attention after securing a US$21 million order for its SiCore cylindrical cells from a leading electric vehicle manufacturer in China, alongside an upcoming first quarter earnings report on May 7, 2026. See our latest analysis for Amprius Technologies. The recent US$21 million EV order and upcoming earnings call sit against a backdrop of strong momentum, with a 90 day share...

Some Scholar Rock Holding Corporation ( NASDAQ:SRRK ) shareholders may be a little concerned to see that the CEO...

Why National Energy Services Reunited is on investors’ radar National Energy Services Reunited (NasdaqCM:NESR) has drawn fresh attention after recent trading, with the stock closing at $23.71 and posting a 0.7% decline over the past day but gains over the past week and month. See our latest analysis for National Energy Services Reunited. Those short term moves sit on top of a much stronger backdrop, with a 90 day share price return of 17.96%, a year to date share price return of 50.16% and a...

Ameresco (NYSE:AMRC) secured a major solar PV project with Cook County, Illinois, adding a substantial renewable asset for the county. The company was awarded eight additional solar projects with Cook County, expanding its public sector clean energy portfolio. Ameresco also signed a new performance savings contract with Miami-Dade County, Florida, focused on energy efficiency and infrastructure upgrades. These announcements highlight Ameresco's expanding role in municipal sustainability and...

Wondering if Ford Motor's share price still offers value, or if the recent run has already done the heavy lifting for you? Over the last year the stock has returned 35.8%, compared with a 7.4% gain over the past month and a 5.3% decline year to date. This can signal shifting expectations around both opportunity and risk. Recent headlines have focused on Ford Motor's position in the US auto market and its ongoing investments in future vehicle platforms. These developments help frame how...

Caris Life Sciences (NasdaqGS:CAI) is promoting its Right-In-Time clinical trial solution, focused on closing the geographic gap in cancer trial access for community oncology practices across the US. The RIT model integrates trial matching into Caris' molecular profiling workflow and is designed to rapidly open eligible trials at local sites when a patient is identified. The initiative targets logistical and systemic barriers that often keep biomarker driven cancer trials concentrated in...

As European markets experience a positive upswing, with the STOXX Europe 600 Index rising by 1.91% amid easing geopolitical tensions and steady corporate earnings, investors are increasingly looking to dividend stocks as a reliable income source. In this context, selecting dividend stocks that offer stable yields can be particularly appealing for those seeking consistent returns in an environment where economic forecasts remain cautious.

We wouldn't blame The Travelers Companies, Inc. ( NYSE:TRV ) shareholders if they were a little worried about the fact...

Wondering if Safran at €272.50 is still offering value after a strong multi year run, or if the easy gains are behind it? This article focuses squarely on what the current price could mean for you. The stock is currently around €272.50, after a 25.6% return over 1 year and a 101.1% return over 3 years. Recent returns of 11.8% over 7 days, 5.2% over 30 days and 11.3% year to date show a pullback that may reflect shifting views on risk and reward. Recent coverage of Safran has focused on its...

DaVita (DVA) is back in focus after recent results showed 9.9% year on year revenue growth, earnings ahead of analyst estimates, and higher reimbursement rates that coincided with upbeat 2026 adjusted EPS guidance. See our latest analysis for DaVita. Investors have reacted strongly to DaVita’s recent results, with a 39.6% 90 day share price return and a 76.7% three year total shareholder return suggesting momentum has been building around the earnings story and reimbursement backdrop. If...

Recent share performance snapshot Pandora (CPSE:PNDORA) has drawn fresh attention after a recent pullback, with the share price down about 4.6% over the past day but slightly higher over the past month. Over the past 3 months, the stock shows a small decline, while year to date performance and the past year’s total return are both negative. This may prompt investors to reassess expectations and risk tolerance. See our latest analysis for Pandora. With the share price at DKK500.4, Pandora’s...

If you are wondering whether American Airlines Group at around US$11.50 is a bargain or a value trap, the starting point is understanding what the current price actually reflects. The stock has had a mixed run, with a 5.5% decline over the last 7 days, a 6.4% gain over the last 30 days, a 25.7% decline year to date and a 23.4% return over the past year. Recent headlines have focused on American Airlines Group's ongoing efforts to manage costs, capacity and debt, as well as industry wide...

If you are wondering whether Magna International's current share price lines up with its underlying worth, this article walks through the key facts to help you frame that question clearly. The stock last closed at $83.91, with returns of 8.2% over 7 days, 13.7% over 30 days, 11.9% year to date, 89.2% over 1 year, 33.8% over 3 years and an 18.3% decline over 5 years. These figures can change how investors think about both potential and risk. Recent coverage around auto components and mobility...

Activist pressure puts Teladoc Health (TDOC) in focus Activist investor Pineal Capital Management is pressing Teladoc Health (TDOC) to launch at least US$200 million in share buybacks and explore separating its Integrated Care and BetterHelp businesses. The push coincides with Teladoc’s work on AI powered safety features alongside Microsoft, putting both capital allocation and product direction under closer scrutiny for investors watching the stock. See our latest analysis for Teladoc...

Wondering whether Protagonist Therapeutics at around US$105.55 still offers value, or if most of the opportunity is already reflected in the price. The stock has posted returns of 0.1% over the past week, 7.1% over 30 days, 21.1% year to date and 128.7% over the last year, which may have shifted how investors think about both its potential and its risks. Recent news coverage has focused on Protagonist Therapeutics as a higher profile biotech name, with attention centered on its pipeline...